These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34779250)
21. Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis. Baharlooi H; Nouraei Z; Azimi M; Moghadasi AN; Tavassolifar MJ; Moradi B; Sahraian MA; Izad M Scand J Immunol; 2021 Jun; 93(6):e13013. PubMed ID: 33338274 [TBL] [Abstract][Full Text] [Related]
22. Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell. Hansen SB; Højgaard LD; Kastrup J; Ekblond A; Follin B; Juhl M Front Immunol; 2022; 13():1085312. PubMed ID: 36578497 [TBL] [Abstract][Full Text] [Related]
23. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells. Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596 [TBL] [Abstract][Full Text] [Related]
24. Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs). Hsu PJ; Liu KJ; Chao YY; Sytwu HK; Yen BL J Vis Exp; 2015 Dec; (106):e53265. PubMed ID: 26780482 [TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory effects of some Namibian plants traditionally used for treating inflammatory diseases. Du Preez CI; Gründemann C; Reinhardt JK; Mumbengegwi DR; Huber R J Ethnopharmacol; 2020 May; 254():112683. PubMed ID: 32087321 [TBL] [Abstract][Full Text] [Related]
26. In vitro analysis of equine, bone marrow-derived mesenchymal stem cells demonstrates differences within age- and gender-matched horses. Carter-Arnold JL; Neilsen NL; Amelse LL; Odoi A; Dhar MS Equine Vet J; 2014 Sep; 46(5):589-95. PubMed ID: 23855680 [TBL] [Abstract][Full Text] [Related]
27. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Schnabel LV; Pezzanite LM; Antczak DF; Felippe MJ; Fortier LA Stem Cell Res Ther; 2014 Jan; 5(1):13. PubMed ID: 24461709 [TBL] [Abstract][Full Text] [Related]
28. Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility. Harman RM; Patel RS; Fan JC; Park JE; Rosenberg BR; Van de Walle GR Stem Cell Res Ther; 2020 Dec; 11(1):524. PubMed ID: 33276815 [TBL] [Abstract][Full Text] [Related]
32. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties. Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718 [TBL] [Abstract][Full Text] [Related]
33. Potential surrogate quantitative immunomodulatory potency assay for monitoring human umbilical cord-derived mesenchymal stem cells production. Teng SW; Sung HY; Wen YC; Chen SY; Lovel R; Chang WY; Wu TB; Hsuan YC; Lin W Cell Biol Int; 2021 May; 45(5):1072-1081. PubMed ID: 33470478 [TBL] [Abstract][Full Text] [Related]
34. Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells. Naskou MC; Sumner SM; Chocallo A; Kemelmakher H; Thoresen M; Copland I; Galipeau J; Peroni JF Stem Cell Res Ther; 2018 Mar; 9(1):75. PubMed ID: 29566772 [TBL] [Abstract][Full Text] [Related]
35. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810 [TBL] [Abstract][Full Text] [Related]
36. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors. Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG Front Immunol; 2020; 11():54. PubMed ID: 32117234 [TBL] [Abstract][Full Text] [Related]
37. A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance. Ketterl N; Brachtl G; Schuh C; Bieback K; Schallmoser K; Reinisch A; Strunk D Stem Cell Res Ther; 2015 Dec; 6():236. PubMed ID: 26620155 [TBL] [Abstract][Full Text] [Related]